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ABSTRACT
Objective: The aims of this point-prevalence study
were to investigate a representative inpatient
population to determine the prevalence of people
admitted to hospital for the reason of a foot-related
condition, and identify associated independent
factors.
Methods: Participants were adult inpatients in 5
different representative hospitals, admitted for any
reason on the day of data collection. Maternity,
mental health and cognitively impaired inpatients
were excluded. Participants were surveyed on a
range of self-reported demographic, social
determinant, medical history, foot disease history,
self-care, footwear, past foot treatment prior to
hospitalisation and reason for admission variables.
Physical examinations were performed to clinically
diagnose a range of foot disease and foot risk factor
variables. Independent factors associated with being
admitted to hospital for the primary or secondary
reason of a foot-related condition were analysed
using multivariate logistic regression.
Results: Overall, 733 participants were included;
mean (SD) age 62 (19) years, male 55.8%. Foot-
related conditions were the primary reason for
admission in 54 participants (7.4% (95% CI 5.7% to
9.5%)); 36 for foot disease (4.9%), 15 foot trauma
(2.1%). Being admitted for the primary reason of a
foot-related condition was independently associated
with foot infection, critical peripheral arterial
disease, foot trauma and past foot treatment by a
general practitioner and surgeon (p<0.01). Foot-
related conditions were a secondary reason for
admission in 28 participants (3.8% (2.6% to 5.6%)),
and were independently associated with diabetes and
current foot ulcer (p<0.01).
Conclusions: This study, the first in a
representative inpatient population, suggests the
direct inpatient burden caused by foot-related
conditions is significantly higher than previously
appreciated. Findings indicate 1 in every 13
inpatients was primarily admitted because of a foot-
related condition with most due to foot disease or
foot trauma. Future strategies are recommended to
investigate and intervene in the considerable
inpatient burden caused by foot-related conditions.
INTRODUCTION
Foot-related conditions can cause high
burdens of disease due to high rates of hospi-
talisation and amputation.1–6 In the context
of hospitalisation, foot-related conditions typ-
ically refer to foot disease or foot trauma.1–10
Foot disease typically refers collectively to
ulcers, infections, ischaemia and Charcot foot
and is usually precipitated by the foot risk
factors of peripheral arterial disease (PAD),
neuropathy and deformity.1–4 10–12 Foot
trauma typically refers to limb-threatening
injuries to the foot caused by high energy
trauma.8 9
Foot-related conditions have been reported
to be present in considerable proportions of
speciﬁc inpatient populations.1–7 Yet, recent
reviews conclude the direct foot-related
inpatient burden has yet to be studied; that
is, the total prevalence of all hospitalisations
caused by any foot-related condition within
a representative inpatient population.1 2
One large retrospective study of a national
hospital discharge data set reported that
1.2% of all hospitalisations were caused by
Strengths and limitations of this study
▪ This is the first study to investigate the preva-
lence of people admitted to hospital because of
any foot-related condition within a representative
inpatient population.
▪ This study investigated inpatients from five dif-
ferent hospitals considered to be representative
of inpatient populations in Australia.
▪ Data collectors had specific training and high
accuracy in collecting standard self-reported
medical history and clinically diagnosed
foot-related condition variables.
▪ As a point-prevalence study, findings are reliant
on the days surveyed being representative of
standard activity and are unable to determine
causal relationships.
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foot disease; however, it did not report foot trauma.5
Therefore, there is a distinct gap in information to quan-
tify the direct inpatient burden caused by foot-related
conditions.1 2 Without this information, it is difﬁcult for
clinicians, researchers and policymakers to comprehend,
compare and address a burden of disease.13
Thus, the primary aim of this point-prevalence study
was to investigate a representative inpatient population
to determine the prevalence of people admitted to hos-
pital for the primary or secondary reason of a foot-related
condition. A secondary aim was to investigate the inde-
pendent factors associated with being admitted to hos-
pital for the reason of a foot-related condition.
METHODS
Study design
This study was the ﬁrst in the Foot Disease in Inpatients
Study (FDIS) research project. The main objective of
FDIS was to investigate the prevalence, and associated
factors, of different foot disease disorders and foot risk
factors in a representative inpatient population. This was
a multisite observational point-prevalence cross-sectional
study set in ﬁve public hospitals in Queensland,
Australia. The authors have adhered to the STROBE
reporting checklist for cross-sectional studies (see online
supplementary table S1). Site-speciﬁc authority was also
obtained from each hospital, and written informed
consent was voluntarily obtained from all participants.
Settings
Five public hospitals made up the sites for this study: (1)
a major metropolitan hospital (>500 beds) with a catch-
ment population of 900 000 in south Queensland; (2)
major metropolitan specialty (>500 beds) with a catch-
ment population of 900 000 in south Queensland; (3)
major regional (200–500 beds) with a catchment popula-
tion of 220 000 in central Queensland; (4) large metro-
politan (200–500 beds) with a catchment population of
250 000 in south Queensland and (5) large regional hos-
pital (50–99 beds) with a catchment population of 30 000
in north Queensland. These hospitals were purposively
selected by the authors to maximise the population-based
generalisability of any ﬁndings by representing each of
the different deﬁned categories of peer group hospitals in
Australia according to the National Health Performance
Authority:14 major metropolitan, major regional, large
metropolitan, large regional and medium hospitals.14
Specialist hospitals are unable to be deﬁned into these
peer groups;14 thus, the authors decided to include a
major metropolitan specialist hospital instead of a
medium hospital to further maximise generalisability.
As a point-prevalence study, each hospital had data
collected on one day. Practical resource implications
meant the same day could not be chosen for all hospi-
tals. After consultation with senior hospital manage-
ment, a mid-week day (Tuesday to Thursday) was
considered to be most representative of standard
hospital activity. The designated day for each hospital
was decided by the authors according to resource, travel
and data collector availability. Data collection days for
hospitals in similar regions were separated by 2 months
to minimise the possibility of the same participant
admission being captured twice. Data collection days
were in 2013: major metropolitan (September), major
metropolitan specialty ( July), major regional ( June),
large metropolitan (December) and large regional hos-
pital ( June).
Participants
Eligible participants were all adult inpatients (>18 years)
present between 8:00 and 17:00 in the hospital on the
designated data collection day. An inpatient was deﬁned
as a person admitted for at least one night of hospital
care for any reason, either the night prior or the night
of the designated data collection day as conﬁrmed by
the treating medical ofﬁcer. Exclusion criteria included
those <18 years of age; those with a cognitive deﬁcit as
determined by the Nurse Unit Manager; or those in a
paediatric, maternity or psychiatric ward. These criteria
are typical of point-prevalence inpatient studies.15–18
Sample size calculation
An inpatient prevalence of 4.6% was chosen as the basis
for the sample size calculation.1 This was chosen as a
recent systematic review reported that foot wounds had
been the most investigated of all inpatient foot-related
conditions and 4.6% was the reported pooled preva-
lence estimate for inpatient foot wounds from this
review.1 Therefore, a sample size of 750 participants was
calculated for this study based on an inpatient preva-
lence of 4.6%, a 95% CI of 3.1% to 6.1%, and an α level
of 0.05.
Data collection instrument
A Queensland Foot Disease Form (QFDF) data collec-
tion instrument was used to collect all variables
(ﬁgure 1). The QFDF was modiﬁed from a similar vali-
dated data collection instrument, the Queensland High
Risk Foot Form (QHRFF).19 In brief, the QHRFF col-
lects 46 items via self-reported history and clinical diag-
noses of foot-related conditions.19 20 Modiﬁcations to
the QHRFF to develop the QFDF included enacting any
changes recommended by its original authors;19 remov-
ing variables not applicable to this study and adding vari-
ables identiﬁed from recent systematic reviews to be
applicable to foot-related conditions in inpatients1 2 21
such as reason for admission.1 5 22 The 57-item QFDF
contained 36 (78%) of the 46 items that were extensively
tested for reliability and validity in the QHRFF.19 The
authors decided to further test the QFDF by testing the
accuracy of data collectors using the QFDF against simu-
lated cases, and testing the concurrent validity of a sub-
sample of study data collected using the QFDF
compared with medical records audited for the same
data. Both testing procedures are described below.
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Variables collected
Table 1 outlines the criteria, deﬁnitions and support-
ing citations5 8–11 19–39 used for each individual vari-
able collected by the QFDF in this study. Patient
explanatory variables were self-reported and grouped
into ward, demographic, social determinant, medical
condition history, self-care ability, past foot treatment
and foot disease history variables. Foot explanatory
variables were clinically diagnosed and grouped into
foot risk factors, foot disease and foot risk status. The
outcome variable of interest for this study was the self-
reported identiﬁcation of a foot-related condition as
the participant’s primary or secondary reason for
admission. From those participants reporting a
foot-related condition as a reason for admission, the
foot explanatory variable considered to most likely
have caused the admission was identiﬁed and termed
the predominant foot-related condition causing ad-
mission. Trained data collectors administered all
variables.
Figure 1 QFDF data collection
instrument. CKD, chronic kidney
disease; CVA, cardiovascular
accident; ESKD, end-stage
kidney disease; GP, general
practitioner; HbA1c, glycated
haemoglobin; MI, myocardial
infarct; PAD, peripheral arterial
disease; QFDF, Queensland Foot
Disease Form; UTWCS,
University of Texas Wound
Classification System.
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Table 1 Definitions for each item of the QFDF
QFDF item Definition
Ward
Surgical ward Participant is in a ward for the purpose of a surgical procedure23
Medical ward Participant is in a ward not for the purpose of a surgical procedure23
Demographics
Age Participant’s age in whole years at time of data collection19 21 23 24
Sex Participant is male, female or other19 21 23 24
Social determinants
Socioeconomic status Participant’s postcode of usual residence was used to determine Australian Index of Relative
Social Disadvantage status21 25
Geographical remoteness Participant’s postcode of usual residence was used to determine Accessibility/Remoteness
Index of Australia status21 26
Highest education level
achieved
What is the highest education qualification level you have achieved?21 24 27
Born overseas In which country were you born?24 27
Indigenous status Are you of Aboriginal or Torres Strait Islander origin?19 23 24
Medical condition history
Diabetes Have you ever been told by a doctor or nurse that you have had diabetes? (Should have
lasted or likely to last for 6+ months)19 21 24 27 28
Diabetes type If yes to diabetes, which type of diabetes do you have: type 1 or type 2?19 21 24 28
Hypertension Have you ever been told by a doctor or nurse that you have had hypertension or high blood
pressure? (Should have lasted or likely to last for 6+ months)19 24 27
Dyslipidaemia Have you ever been told by a doctor or nurse that you have had dyslipidaemia or high
cholesterol? (Should have lasted or likely to last for 6+ months)19 24
MI Have you ever been told by a doctor or nurse that you have had MI or heart attack? (Should
have lasted or likely to last for 6+ months)19 21 24
CVA Have you ever been told by a doctor or nurse that you have had cardiovascular attack or
stroke? (Should have lasted or likely to last for 6+ months)19 21 24 27
CKD Have you ever been told by a doctor or nurse that you have had CKD? (Should have lasted
or likely to last for 6+ months)19 21
ESKD Have you ever been told by a doctor or nurse that you have had kidney failure or do you
need dialysis? (Should have lasted or likely to last for 6+ months)19
Cancer Have you ever been told by a doctor or nurse that you have had cancer? (Should have lasted
or likely to last for 6+ months)21 27
Arthritis Have you ever been told by a doctor or nurse that you have had arthritis? (Should have
lasted or likely to last for 6+ months)27
Depression Have you ever been told by a doctor or nurse that you have had depression? (Should have
lasted or likely to last for 6+ months)24 27
Acute foot trauma Have you had major trauma to your feet that resulted in a fracture, burn, wound or infection
that required hospital treatment?8 9
Smoker Are you a current smoker?19 21 24 27
Ex-smoker If no to smoker, did you ever smoke?19 21 24 27
Self-care ability
Mobility impairment Are you able to walk without the help of an aide?11 21
Vision impairment Are you able to read a newspaper (with glasses if needed)11 21
Footwear worn: inside From a sheet displaying 16 different types of footwear: What is the type of shoes you have
worn most inside the house over the past 12 months?21 29 30
Footwear worn: outside From a sheet displaying 16 different types of footwear: What is the type of shoes you have
worn most outside the house over the past 12 months?21 29 30
Low-risk footwear Participant identified picture of walking shoe, runner, oxford shoe, boot or bespoke footwear
as footwear worn most29 30
Moderate-risk footwear Participant identified picture of moccasin, ugg boot, slipper or backless slipper as footwear
worn most29 30
High-risk footwear Participant identified picture of high heels, flip flop, court shoe, mule or sandal as footwear
worn most29 30
No footwear worn Participant identified picture of socks only or barefoot as footwear worn most29 30
Continued
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Table 1 Continued
QFDF item Definition
Past foot treatment
Yes Have you been treated for a foot problem in the past 12 months? (Excluding in the current
admission)19 31
Podiatry Have you been treated for a foot problem by a podiatrist in the past 12 months? (Excluding in
the current admission)19 31
GP Have you been treated for a foot problem by a GP in the past 12 months? (Excluding in the
current admission)19 31
Physician Have you been treated for a foot problem by another medical physician in the past
12 months? (Excluding in the current admission)19 31
Surgeon Have you been treated for a foot problem by a surgeon in the past 12 months? (Excluding in
the current admission)19 31
Nurse Have you been treated for a foot problem by a nurse in the past 12 months? (Excluding in the
current admission)19 31
Orthotist Have you been treated for a foot problem by an orthotist in the past 12 months? (Excluding in
the current admission)19 31
Other Have you been treated for a foot problem by any other health professional/s in the past
12 months? (Excluding in the current admission)19 31
Foot disease history
Previous PN Have you ever been told by a doctor or nurse that you have had PN? (Should have lasted or
likely to last for 6+ months)19
Previous PAD Have you ever been told by a doctor or nurse that you have had PAD? (Should have lasted
or likely to last for 6+ months)19 21
Previous foot ulcer Have you ever had a foot ulcer that has healed?19 21
Previous amputation Have you ever had an amputation? Plus, a clinical examination to verify previous healed
lower extremity amputation site19 21
Foot risk factors
PN A lack of protective sensation to a 10 g monofilament on at least 2 of 3 plantar forefoot
locations on at least one foot11 19 28 32 33
PAD Absence of at least one palpable foot pulse and a toe systolic pressure <70 mm Hg on at
least one foot10 19 33–35
Mild PAD Toe systolic pressure=51–70 mm Hg10 19 33–35
Moderate PAD Toe systolic pressure=31–50 mm Hg10 19 35 36
Critical PAD (ischaemia) Toe systolic pressure=<30 mm Hg10 19 33 35
Foot deformity A score of at least 3 using the 6-point foot deformity score on at least one foot (1 point each
allocated for small muscle wastage, bony prominence, prominent metatarsal heads, hammer/
claw toes, limited joint mobility and Charcot deformity)19 29 32
Foot disease
Acute Charcot A red, hot, swollen, unilateral neuropathic foot without a local foot wound on at least one
foot19 28 32
Current foot ulcer Do you have a current foot ulcer or sore? Plus, a clinical examination to verify a full thickness
wound beneath the ankle19 37
Current foot infection At least 2 manifestations of inflammation beneath the ankle (purulence, erythema, pain,
tenderness, warmth or induration)19 33 38 39
Foot risk status
Low risk Nil foot disease history or clinical diagnosis of current foot disease, PN or PAD identified
during the clinical examination19 32
At risk Clinical diagnosis of PN and/or PAD (excluding critical PAD) identified during the clinical
examination19 32
High risk Clinical diagnosis of critical PAD, or, foot deformity with PN and/or PAD, or, self-reported
previous foot ulcer or amputation19 32
Acute Current foot wound or acute Charcot19 32
Foot-related condition admission
Primary reason for
admission
Is a foot condition the main reason for your hospital admission?5 20 22 23
Secondary reason for
admission
Is a foot condition another reason for your hospital admission?5 22 23
CKD, chronic kidney disease; CVA, cardiovascular accident; ESKD, end-stage kidney disease; GP, general practitioner; MI, myocardial infarct;
PAD, peripheral arterial disease; PN, peripheral neuropathy; QFDF,Queensland Foot Disease Form.
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Data collection procedure
Data collector training
Data collectors were 27 publicly employed podiatrists
who routinely used the QHRFF in their existing clinical
practice. Data collectors were assisted by 25 ﬁnal year
undergraduate podiatry students and 4 publicly
employed other staff. The role of the assistants was to
help the data collectors with administering the consent-
ing and self-reported history processes only. All data col-
lectors and assistants participated in a 3-hour training
session <1 month prior to their designated data collec-
tion day.
Data collector testing
All data collectors were tested on their use of the
57-item QFDF, using simulated cases to assess their data
collection accuracy immediately pretraining and post-
training session. A minimum of 80% accuracy on the
57-item simulated cases was required to be endorsed as
a data collector and differences in pretraining and post-
training scores were analysed.
Data collection
Data collection occurred between 8:00 and 17:00 on the
designated day. Data collection teams of up to eight
people were allocated up to ﬁve wards of potentially eli-
gible participants for data collection. After completing
the voluntary consenting procedure, included partici-
pants were questioned to determine their self-report
history variables. Participants were then shown a foot-
wear form (modiﬁed with permission from Barton
et al30) containing 16 footwear styles to identify their
main footwear worn inside and outside the house in the
previous 12 months. All participants then underwent a
non-invasive physical examination by a data collector to
determine their clinically diagnosed variables. All partici-
pant data were recorded on the QFDF and all com-
pleted QFDF data collection forms were checked at the
conclusion of each hospital data collection day by the
authors for errors or omissions. Any missing data or
potential data errors were clariﬁed with the data col-
lector concerned.
Data collector audit
As aforementioned, a subsample of data collected from
participants (study data) was tested for concurrent valid-
ity with the participants’ medical records (medical
records). As the study was conducted in different
regions, a random sample was unable to be tested due
to resource constraints. Therefore, to be representative
of the different wards and hospitals in the study, a sub-
sample (∼5% of the required study sample size) was
taken from one general medical and one general surgi-
cal ward located in the large metropolitan hospital,
which was the third largest (middle-sized) hospital. The
process for the audit involved ﬁrst collecting the study
data from the subsample of participants as per the data
collection procedure. The hospital medical records of
those participants included in the subsample were then
audited on the same day by two authors who were
blinded to the subsample study data collected. The
authors were instructed to review the medical record
and complete all applicable variables if noted anywhere
in the medical record using a QFDF. The applicable vari-
ables recorded from the medical records were then com-
pared with the study data collected for agreement.
Statistical analysis
All data were analysed using SPSS V.22.0 for Windows
(SPSS, Chicago, Illinois, USA) or GraphPad Software.
Descriptive statistics were used to display all variables,
using means and SDs for continuous variables or propor-
tions for categorical variables. Prevalence with 95% CIs
were calculated using a modiﬁed Wald method for
outcome variables.40 χ2 or Kruskal-Wallis tests were used
to test differences between hospitals for categorical vari-
ables and t-tests or analysis of variance to test differences
between hospitals for continuous variables.41 Univariate
logistic regression analyses were undertaken to test for
crude associations with the outcomes.41–43
Multivariate logistic regression was used to analyse for
independent associations.42 43 As this study was investi-
gating a new ﬁeld, a data-driven backwards stepwise
method was chosen.42 43 All variables achieving crude
associations (p<0.2), except those deemed illogical, were
entered into the backwards stepwise model, non-
signiﬁcant variables (p>0.05) were removed at each step,
until only variables achieving statistical signiﬁcance
remained (p<0.05) and their ORs reported (unadjusted
model).42 43 This model method was consistent with
similar foot-related studies.31 36 44–46 Collinearity was
tested for all models using correlation matrix (>0.9), tol-
erance (<0.1) and variance inﬂation factor (>10).42 43 If
collinearity was identiﬁed, the variable with the lowest
OR in the univariate analysis was removed. The Hosmer
and Lemeshow goodness of ﬁt, Omnibus and
Negelkerke pseudo R2 tests were used at each step of all
models to indicate goodness of ﬁt, signiﬁcance, parsi-
mony and potential variance of the outcome variable
explained by the model, respectively.42 43 The ﬁnal
unadjusted model was then tested for confounding by
re-entering in each non-included explanatory variable to
see if it confounded the independent explanatory vari-
ables in the unadjusted model.42 43 A confounder was
deﬁned, and remained in the model, as changing the β
effect estimates of at least one unadjusted independent
explanatory variables by >20% (adjusted model).42 Two
different multivariate models were assessed for each
outcome variable. The ﬁrst used all available explanatory
variables, except the summarised foot risk status variable
(model 1). The second used the summarised foot risk
status variable, instead of foot disease history, foot risk
factors and foot disease explanatory variables (model 2).
Missing data were treated by excluding cases with
missing data as missing data were minimal (<5% in all
models).42
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Lastly, κ for dichotomous variables, weighted κ (wK)
for ordinal variables and intraclass correlation (ICC;
models 2 and 1) for continuous variables were used to
test for measures of agreement for the data collector
testing and audit.41 47 48 κ and wK (SEs ) strengths were
categorised as: no agreement <0; slight agreement=0–0.20;
fair agreement=0.21–0.40; moderate agreement=0.41–0.6;
substantial agreement=0.61–0.8 and near-perfect agree-
ment=0.81–1.0.41 47 48 ICC (SD) strengths were cate-
gorised as: weak–moderate agreement <0.75 and strong
agreement >0.75.41
RESULTS
Characteristics
Online supplementary table S2 reports the demographic
characteristics of the 1146 total inpatients present
during the study. Of these, 263 (23%) patients were
non-eligible and excluded: 248 due to cognitive impair-
ment and 15 for other reasons (including children,
non-English speaking or unavailable). Non-eligible
patients were older (p<0.001) with no differences in sex
(p=0.717). Of the 883 eligible patients, 733 (83%) con-
sented. There were no differences in age (p=0.187)
or sex (p=0.198) between those consenting and
non-consenting.
Table 2 reports the characteristics of the 733 included
participants. Overall, mean age (SD) was 62.0 (18.6)
years and 55.8% were males. Differences were evident
between hospitals for demographic, social determinant,
medical history, self-care ability, past foot treatment, foot
disease history and foot risk status variables (p<0.05).
No differences between hospitals were recorded for foot
risk factor and foot disease variables (p<0.05).
Prevalence
Primary reason for admission for foot-related conditions
were identiﬁed in 54 participants (7.4% (95% CI 5.7%
to 9.5%)) and 15 of those had diabetes (2.0% (1.2% to
3.4%); table 2). The predominant causes of these were
foot disease in 36 participants (4.9% (3.6% to 6.7%); 17
foot infection, 13 critical PAD, 6 foot ulcer), foot trauma
in 15 participants (2.1% (1.2% to 3.4%)) and 3 others
were unable to be determined with the variables col-
lected. Higher proportions of primary foot-related
admissions existed in the major regional (12.2%) and
major metropolitan general hospitals (10.7%) as com-
pared with the other hospitals (p<0.05).
Secondary reason for admission for foot-related condi-
tions were identiﬁed in 28 participants (3.8% (2.6% to
5.5%)) and 19 of those had diabetes (2.6% (1.6% to
4.0%); table 2). The predominant causes of these were
foot disease in 13 participants (1.8% (1.0% to 3.0%); 9
foot ulcers, 3 foot infections, 1 critical PAD), foot
trauma in 1 (0.1% (0% to 0.8%)) and 14 others were
unable to be determined. No differences in proportions
of secondary foot-related admissions between hospitals
were identiﬁed.
Independent associated factors
Table 3 reports unadjusted and adjusted OR (95% CIs)
for variables achieving signiﬁcance for primary reason
for admission for foot-related conditions. Univariate ana-
lyses (p<0.2) identiﬁed 20 variables eligible for model 1
and 12 for model 2 (see online supplementary table
S3). Current foot ulcer was excluded as collinearity was
identiﬁed with current foot infection. Model 1 identiﬁed
six unadjusted independent associated factors: critical
PAD, current foot infection, acute foot trauma, past
surgeon treatment, past general practitioner (GP) treat-
ment and myocardial infarct (MI) history (all p<0.05).
Identiﬁed confounders were: socioeconomic status, dia-
betes, chronic kidney disease (CKD) and dyslipidaemia.
After adjusting, all factors remained signiﬁcant (all
p<0.01), except MI (p>0.2). Model 2 identiﬁed four
unadjusted independent associated factors: acute foot
risk status, high foot risk status, past surgeon treatment
and past GP treatment (all p<0.05). Identiﬁed confoun-
ders were: diabetes, MI, CKD, acute foot trauma and
past podiatry treatment. After adjusting, all factors
remained signiﬁcant (all p<0.001).
Table 4 reports unadjusted and adjusted OR (95%
CIs) for variables achieving signiﬁcance for secondary
reason for admission for foot-related conditions.
Univariate analyses (p<0.2) identiﬁed 16 variables eli-
gible for model 1 and 10 for model 2 (see online
supplementary table S3). Current foot infection was
excluded as collinearity was identiﬁed with current foot
ulcer. Model 1 identiﬁed two unadjusted independent
associated factors: diabetes and current foot ulcer (both
p<0.001). Identiﬁed confounders were: mobility impair-
ment and previous foot ulcer. After adjusting, both factors
remained signiﬁcant (both p<0.01). Model 2 identiﬁed
two unadjusted independent associated factors: diabetes
and acute foot risk status (both p<0.001). No adjustment
was performed as no confounders were identiﬁed.
Data collector testing and audit results
Online supplementary table S4 reports an improvement
in the data collectors post-training scores compared with
pretraining scores (p<0.001). All participants scored
>90% in the post-test. Online supplementary table S5
reports the strengths of agreement between the study
data and medical records data for the 44 eligible and 28
consenting participants in the subsample. Of the 19
applicable variables tested, 12 (63%) had near-perfect/
strong, 2 (11%) substantial, 3 (16%) moderate and 2
(11%) had fair agreement. In variables reporting less
than near-perfect/strong agreement, study data identi-
ﬁed more cases than medical records.
DISCUSSION
Principal findings
We believe this is the ﬁrst study to investigate the direct
inpatient burden caused by all foot-related conditions
within a representative inpatient population. Our
Lazzarini PA, et al. BMJ Open 2016;6:e010811. doi:10.1136/bmjopen-2015-010811 7
Open Access
group.bmj.com on December 4, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
Table 2 Participant characteristics for each hospital site (number (%) unless otherwise stated)
n Total
Large
regional
Major
regional Large Metro
Major Metro
specialty
Major Metro.
general p Value
Participants 733 733 21 82 90 232 308
Ward
Medical 733 459 (62.6%) 16 (76.2%) 49 (59.8%) 57 (63.3%) 171 (73.7%) 166 (53.9%)
Surgical 733 274 (37.4%) 5 (23.8%) 33 (40.2%) 33 (36.7%) 61 (26.3%) 142 (46.1%) <0.001*
Demographics
Age (SD) years 731 62.0 (18.6) 50.0 (18.0)* 63.5 (19.1) 63.2 (18.3) 65.5 (18.3) 59.5 (18.3)* <0.001*
Age range years 731 18–99 20–85 18–91 21–96 18–99 18–94
Age groups 731
18–40 years 110 (15.0%) 6 (28.6%) 12 (14.6%) 12 (13.3%) 28 (12.1%) 52 (16.9%)
41–60 years 188 (25.7%) 8 (38.1%) 20 (24.4%) 23 (25.6%) 54 (23.4%) 83 (27.0%)
61–80 years 316 (43.2%) 6 (28.6%) 36 (43.9%) 37 (41.1%) 94 (40.7%) 143 (46.6%)
81+ years 117 (16.0%) 1 (4.8%) 14 (17.1%) 18 (20.0%) 55 (23.8%) 29 (9.4%) <0.001*
Male sex 731 408 (55.8%) 13 (61.9%) 52 (63.4%) 46 (51.1%) 127 (54.7%) 170 (55.6%) 0.531
Social determinants
Socioeconomic status 711
Most disadvantaged 102 (14.3%) 6 (28.6%) 4 (5.1%) 30 (34.1%) 23 (10.2%) 39 (13.1%)
Second most disadvantaged 159 (22.4%) 2 (9.5%) 41 (51.9%) 40 (45.5%) 27 (11.9%) 49 (16.5%)
Middle 98 (13.8%) 12 (57.1%) 27 (34.2%) 10 (11.4%) 22 (9.7%) 27 (9.1%)
Second least disadvantaged 240 (33.8%) 1 (4.8%) 5 (6.3%) 8 (9.1%) 131 (58.0%) 95 (32.0%)
Least disadvantaged 112 (15.8%) 0 2 (2.5%) 0 23 (10.2%) 87 (29.3%) <0.001*
Geographic remoteness 711
Major city 435 (61.2%) 1 (4.8%) 1 (1.3%) 54 (61.4%) 179 (79.2%) 200 (67.3%)
Inner regional area 153 (21.5%) 0 40 (50.6%) 26 (29.5%) 36 (15.9%) 51 (17.2%)
Outer regional area 66 (9.3%) 1 (4.8%) 21 (26.6%) 8 (9.1%) 5 (2.2%) 31 (10.4%)
Remote area 30 (4.2%) 2 (9.5%) 13 (16.5%) 0 5 (2.2%) 10 (2.4%)
Very remote area 27 (3.8%) 17 (81.0%) 4 (5.1%) 0 1 (0.4%) 5 (1.7%) <0.001*
Highest education level 731 21 82 90 230 308
Year 10 and under 395 (54.0%) 14 (66.7%) 58 (70.7%) 54 (60.0%) 124 (53.9%) 145 (47.1%)
Year 12 132 (18.1%) 3 (14.3%) 9 (11.0%) 18 (20.0%) 38 (16.5%) 64 (20.8%)
Certificate in trade or
business
74 (10.1%) 2 (9.5%) 9 (11.0%) 10 (11.1%) 25 (10.9%) 28 (9.1%)
Diploma or associate degree 46 (6.3%) 0 5 (6.1%) 5 (5.6%) 17 (7.4%) 19 (6.2%)
Bachelor degree 48 (6.6%) 0 0 1 (1.1%) 12 (5.2%) 35 (11.4%)
Graduate diploma or
certificate
15 (2.1%) 1 (4.8%) 0 2 (2.2%) 6 (2.6%) 6 (1.9%)
Postgraduate degree 18 (2.5%) 1 (4.8%) 1 (1.2%) 0 7 (3.0%) 9 (2.9%)
Other 3 (0.4%) 0 0 0 1 (0.4%) 2 (0.6%) <0.001*
Born overseas 731 161 (22.0%) 2 (9.5%) 11 (13.4%) 20 (22.5%) 53 (22.8%) 75 (24.4%) 0.159
Indigenous 732 34 (4.6%) 10 (47.6%) 5 (6.1%) 3 (3.4%) 8 (3.4%) 8 (2.6%) <0.001*
Continued
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Table 2 Continued
n Total
Large
regional
Major
regional Large Metro
Major Metro
specialty
Major Metro.
general p Value
Medical condition history
Diabetes 733 172 (23.5%) 6 (28.6%) 20 (24.4%) 18 (20.0%) 66 (28.4%) 62 (20.1%) 0.195
Type 2 diabetes† 162 (22.1%) 6 (28.6%) 20 (24.4%) 18 (20.0%) 59 (25.4%) 59 (19.2%) 0.139
Hypertension 733 359 (49.0%) 11 (52.4%) 40 (48.8%) 52 (57.8%) 129 (55.6%) 127 (41.2%) 0.006*
Dyslipidaemia 733 234 (31.9%) 6 (28.6%) 30 (36.6%) 34 (37.8%) 91 (39.2%) 73 (23.7%) 0.001*
Myocardial infarct 733 146 (19.9%) 4 (19.0%) 10 (12.2%) 18 (20.0%) 67 (28.9%) 47 (15.3%) 0.001*
Cerebrovascular accident 733 85 (11.6%) 1 (4.8%) 10 (12.2%) 10 (11.1%) 36 (15.5%) 28 (9.1%) 0.173
Chronic kidney disease 733 89 (12.1%) 1 (4.8%) 9 (11.0%) 15 (16.7%) 31 (13.4%) 33 (10.7%) 0.431
End-stage kidney disease† 733 9 (1.2%) 0 3 (3.7%) 1 (1.1%) 0 5 (1.6%) NA
Cancer 733 174 (23.7%) 1 (4.8%) 19 (23.2%) 26 (28.9%) 43 (18.5%) 85 (27.6%) 0.021*
Arthritis 733 274 (37.4%) 5 (23.8%) 36 (44.4%) 40 (44.4%) 91 (39.2%) 102 (33.1%) 0.100
Depression 733 191 (26.1%) 2 (9.5%) 29 (35.4%) 28 (31.1%) 55 (23.7%) 77 (25.0%) 0.069
Acute foot trauma 733 26 (3.5%) 1 (4.8%) 4 (4.9%) 6 (6.7%) 2 (0.9%) 13 (4.2%) 0.079
Smoker 733 104 (14.2%) 7 (33.3%) 18 (22.0%) 17 (18.9%) 12 (5.2%) 50 (16.2%) <0.001*
Ex-smoker 733 304 (41.5%) 10 (47.6%) 34 (41.5%) 35 (38.9%) 109 (47.0%) 116 (37.7%) 0.256
Self-care ability
Mobility impairment 729 242 (33.2%) 4 (19.0%) 36 (43.9%) 37 (41.1%) 78 (33.8%) 87 (28.5%) 0.020*
Vision impairment 730 110 (15.1%) 2 (9.5%) 10 (12.2%) 12 (13.5%) 41 (17.7%) 45 (14.7%) 0.637
Footwear worn: inside 728
Low-risk footwear 81 (11.1%) 0 9 (11.0%) 5 (5.6%) 29 (12.7%) 38 (12.4%)
Moderate-risk footwear 263 (36.1%) 2 (9.5%) 35 (42.7%) 28 (31.1%) 108 (47.2%) 90 (29.4%)
High-risk footwear 139 (19.1%) 11 (52.4%) 12 (14.6%) 17 (18.9%) 33 (14.4%) 66 (21.6%)
No footwear worn 245 (33.7%) 8 (38.1%) 26 (31.7%) 40 (44.4%) 59 (25.8%) 112 (36.6%) <0.001*
Footwear worn: outside 726
Low-risk footwear 386 (53.2%) 12 (57.1%) 46 (56.1%) 50 (55.6%) 118 (51.5%) 160 (52.6%)
Moderate-risk footwear 75 (10.3%) 1 (4.8%) 8 (9.8%) 10 (11.1%) 34 (14.8%) 22 (7.2%)
High-risk footwear 250 (34.4%) 8 (38.1%) 26 (31.7%) 29 (32.2%) 74 (32.3%) 113 (37.2%)
No footwear worn 15 (2.1%) 0 2 (2.4%) 1 (1.1%) 3 (1.3%) 9 (3.0%) 0.405
Past foot treatment 733
Yes 256 (34.9%) 6 (28.6%) 38 (46.3) 31 (34.4%) 83 (35.8%) 98 (31.8%) 0.167
Podiatrist 180 (24.6%) 4 (19.0%) 21 (25.6%) 23 (25.6%) 70 (30.2%) 62 (20.1%) 0.105
GP 93 (12.7%) 3 (14.3%) 22 (26.8%) 8 (8.9%) 19 (8.2%) 41 (13.3%) <0.001*
Surgeon 36 (4.9%) 0 6 (7.3%) 2 (2.2%) 6 (2.6%) 22 (7.1%) 0.050
Physician 21 (2.9%) 2 (9.5%) 7 (8.5%) 0 4 (1.7%) 8 (2.6%) 0.002*
Nurse 20 (2.7%) 1 (4.8%) 3 (3.7%) 0 6 (2.6%) 10 (3.2%) 0.486
Orthotist 4 (0.5%) 0 1 (1.2%) 1 (1.1%) 0 2 (0.6%) NA
Other 9 (1.2%) 3 (14) 0 1 (1.1%) 0 5 (1.6%) NA
Foot disease history
Previous peripheral
neuropathy
728 99 (13.6%) 0 9 (11.0%) 13 (14.4%) 20 (8.7%) 57 (18.8%) 0.004*
Previous PAD 728 97 (13.3%) 1 (4.8%) 7 (8.5%) 13 (14.4%) 17 (7.4%) 59 (19.4%) 0.001*
Continued
LazzariniPA,etal.BM
J
Open
2016;6:e010811.doi:10.1136/bm
jopen-2015-010811
9
O
p
e
n
A
c
c
e
s
s
group.bmj.com
 o
n
 D
ecem
ber 4, 2016 - Published by 
http://bmjopen.bmj.com/
D
ow
nloaded from
 
Table 2 Continued
n Total
Large
regional
Major
regional Large Metro
Major Metro
specialty
Major Metro.
general p Value
Previous foot ulcer 731 72 (9.8%) 1 (4.8%) 6 (7.3%) 9 (10.0%) 17 (7.4%) 39 (12.7%) 0.228
Previous amputation 731 30 (4.1%) 0 2 (2.4%) 3 (3.3%) 6 (2.6%) 19 (6.2%) 0.181
Foot risk factors
Peripheral neuropathy 728 160 (22.0%) 3 (14.3%) 24 (29.6%) 16 (17.8%) 58 (25.1%) 59 (19.3%) 0.137
PAD 728
Mild PAD 69 (9.5%) 2 (9.5%) 7 (8.5%) 8 (8.9%) 25 (10.8%) 27 (8.9%)
Moderate PAD 51 (7.0%) 0 5 (6.1%) 7 (7.8%) 18 (7.8%) 21 (6.9%)
Critical PAD 33 (4.5%) 1 (4.8%) 2 (2.4%) 3 (3.3%) 8 (3.5%) 19 (6.3%) 0.887
Foot deformity 706 158 (22.4%) 2 (9.5%) 13 (16.0%) 20 (22.7%) 51 (22.5%) 72 (24.9%) 0.293
Foot disease
Acute Charcot 730 2 (0.3%) 0 0 0 2 (0.9%) 0 NA
Current foot ulcer 732 46 (6.3%) 0 6 (7.3%) 5 (5.6%) 10 (4.3%) 25 (8.1%) 0.298
Current foot infection 723 24 (3.3%) 0 5 (6.2%) 3 (3.3%) 5 (2.2%) 11 (3.6%) 0.405
Foot risk status 731
Low risk 445 (60.9%) 15 (71.4%) 43 (52.4%) 59 (65.6%) 132 (57.1%) 196 (63.8%)
At risk 111 (15.2%) 1 (4.8%) 20 (24.4%) 9 (10.0%) 50 (21.6%) 31 (10.1%)
High risk 109 (14.9%) 4 (19.0%) 8 (9.8%) 16 (17.8%) 37 (16.0%) 44 (14.4%)
Acute 66 (9.0%) 1 (4.8%) 11 (13.4%) 6 (6.7%) 12 (5.2%) 36 (11.7%) 0.001*
Foot-related condition admission
(95% CI)
732 82 (11.2%) (9.1 to 13.7) 1 (4.8%) 13 (15.9%) 6 (6.7%) 14 (6.0%) 48 (15.6%) 0.002*
Primary reason (95% CI) 732 54 (7.4%) (5.7 to 9.5) 1 (4.8%) 10 (12.2%) 5 (5.6%) 5 (2.2%) 33 (10.7%) 0.002*
Secondary reason (95% CI) 732 28 (3.8%) (2.6 to 5.5) 0 3 (3.7%) 1 (1.1%) 9 (3.9%) 15 (4.9%) NA
*p Value of <0.05.
†Numbers also included in overall condition. GP, general practitioner; Metro, metropolitan; NA, not applicable to test as the assumption of χ2 test is violated as two cells had expected count <5;
PAD, peripheral arterial disease.
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ﬁndings indicate 7.4% of all inpatients were hospitalised
for the primary reason of a foot-related condition,
including 4.9% for foot disease and 2.1% foot trauma.
Interestingly, only 28% of those had diabetes. An add-
itional 3.8% were hospitalised with a foot-related condi-
tion as a secondary reason for admission, including
1.8% for foot disease and 0.1% for foot trauma. Being
admitted for the primary reason of a foot-related condi-
tion was independently associated with having critical
PAD, foot infection, foot trauma or past foot treatment
by a surgeon or GP. Whereas, being admitted for a sec-
ondary reason of a foot-related condition was inde-
pendently associated with having diabetes or a current
foot ulcer. Overall, these ﬁndings suggest the direct
inpatient burden caused by foot-related conditions is
signiﬁcantly higher than previously reported, affecting
1 in 13 inpatients with the majority not related to
diabetes.
Interpretations of findings
The large disparity between our 7.4% direct foot-related
inpatient burden ﬁnding and the 1.2% in the only previ-
ous similar study5 may be explained by a number of
methodological differences. The previous study retro-
spectively investigated foot disease codes only from a
standard hospital discharge data set to identify patients,5
compared with our study which prospectively examined
for all possible foot-related conditions. Yet, our study still
reported a much higher rate for those hospitalised for
foot disease (4.9%) compared with the previous study
(1.2%).5 Retrospective analyses compared with prospect-
ive examinations have been found to under-report
foot-related admissions in the same Australian inpatient
population by threefold.12 Additionally, the previous
study investigated hospital admissions,5 whereas our
study investigated a one occupied hospital bed day
period. Foot-related admissions use threefold the
number of bed days than average hospital admissions in
Australia.3 6 These methodological improvements com-
pared with the previous study suggest our ﬁndings are
plausible and much higher than previously reported.
We found only 28% of foot-related hospitalisations
were in people with diabetes which was similar to the
15% reported in the previous study.5 This suggests the
majority of the inpatient foot-related burden may not be
caused by diabetes as has been traditionally considered.3 4
Our ﬁndings equate to 2.0% of all inpatients, on a given
day, being in hospital because of diabetes-related foot
disease in Queensland. Considering a recent retrospect-
ive study of the Queensland hospital discharge data set
identiﬁed that 0.9% of all hospital bed days in
Queensland were primarily used to manage diabetes-
related foot disease,6 and the under-reporting in retro-
spective studies,12 our ﬁndings again seem plausible. Our
Table 3 Independent associated factors for primary admissions for foot-related conditions using multivariate logistical
regression (ORs (95% CI))
Risk factor Unadjusted p Value Adjusted p Value
Model 1
Myocardial infarct 0.15 (0.03 to 0.70) 0.016* 0.34 (0.06 to 1.90) 0.219
Acute foot trauma 29.49 (7.28 to 119.48) <0.001* 73.32 (15.86 to 338.92) <0.001*
PAD <0.001* <0.001*
Nil PAD Referent Referent
Mild PAD 0 NA 0 NA
Moderate PAD 2.37 (0.62 to 9.04) 0.207 5.45 (1.05 to 28.23) 0.044
Critical PAD 53.60 (16.82 to 170.84) <0.001* 140.56 (30.82 to 641.04) <0.001*
Current foot infection 29.39 (7.52 to 114.83) <0.001* 53.11 (9.89 to 285.17) <0.001*
Past GP treatment 4.65 (1.64 to 13.20) 0.004* 7.61 (2.30 to 25.19) 0.001*
Past surgeon treatment 5.88 (1.66 to 20.81) 0.006* 6.98 (1.91 to 25.54) 0.003*
Model 1 results: Pseudo R2: 0.602;
Omnibus: df=8, p=<0.001
Missing: 14 (1.9%);
H&L: p=0.013
Pseudo R2: 0.657;
Omnibus: df=15,
p=<0.001
Missing: 36 (4.9%);
H&L: p=0.880
Model 2 + Past foot treatment
Foot risk status <0.001* <0.001*
Low risk Referent Referent
At risk 1.66 (0.15 to 18.76) 0.682 2.01 (0.18 to 23.16) 0.574
High risk 23.12 (5.05 to 105.95) <0.001* 39.57 (8.15 to 192.05) <0.001*
Acute 181.44 (40.52 to 812.51) <0.001* 158.63 (30.34 to 829.51) <0.001*
Past GP treatment 2.70 (1.17 to 6.25) 0.020* 6.40 (2.36 to 17.40) <0.001*
Past surgeon treatment 4.31 (1.49 to 12.44) 0.007* 11.62 (3.46 to 39.03) <0.001*
Model 2 results: Pseudo R2: 0.582;
Omnibus: df=5, p=<0.001
Missing: 2 (0.3%);
H&L: p=0.861
Pseudo R2: 0.638;
Omnibus: df=10,
p=<0.001
Missing: 2 (0.3%);
H&L: p=0.954
*p<0.05.df, degrees of freedom; H&L, Hosmer and Lemeshow test; missing, excluded missing cases; NA, not applicable; Omnibus, Omnibus
tests of model coefficients; Pseudo R2, Nagelkerke R2; GP, general practitioner; PAD, peripheral arterial disease.
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ﬁndings also appear generalisable when interpreting dia-
betes rate trends between ours and other regions. The
23.5% inpatient diabetes prevalence found in our
Queensland study is similar to the 24.7% reported in
Victoria (Australia),17 26.2% in the USA,49 50 but higher
than 15.8% in the UK.51 The diagnosed diabetes popula-
tion prevalence in Queensland is 4.5% and 5.0% in
Victoria;52 while the estimated national diabetes popula-
tion prevalence for Australia is 7.8%, 9.2% in the USA
and 4.9% in the UK.53 Also diabetes-related amputation
rates, often used as a surrogate measure of the foot
disease burden, showed similar trends with 15 per
100 000 people reported in Queensland,6 18 in Australia,
36 in the USA and 9 in the UK.54 55 These interpretations
suggest our ﬁndings are plausible and potentially gener-
alisable to other regions.
Our study also found that nearly all those primarily hos-
pitalised for a foot-related condition were due to foot
disease (67%) or foot trauma (28%). These ﬁndings were
supported by our multivariate models reporting they were
independantly associated with a foot disease disorder (crit-
ical PAD, foot infection or foot ulceration), foot trauma or
had previous foot treatment from a GP or surgeon. These
same independent associates have been consistently identi-
ﬁed in diabetes inpatient populations;10 11 37 38 however,
our ﬁndings adjusted for diabetes in a representative
inpatient population. Furthermore, after adjustment, inpa-
tients classiﬁed with acute foot risk status were much more
likely to be in hospital for the primary reason of a
foot-related condition than those of lower foot risk status.
This suggests, regardless of diabetes, that using a diabetes
foot risk status system19 32 may be useful to identify people
highly likely to be admitted to hospital because of a
foot-related condition.
In addition to those primarily hospitalised for a
foot-related condition, 3.8% of participants reported a
foot-related condition as a secondary reason for their
admission. This meant the participant had been primar-
ily admitted for another health condition, yet also
required treatment in hospital to manage a foot-related
condition.23 To the best of the authors’ knowledge, no
study has investigated the prevalence of secondary
foot-related admissions. Participants with a secondary
foot-related condition were more likely to have diabetes
or a current foot ulcer. This is not surprising considering
people with diabetes have very high rates of foot-related
conditions compared with other disease processes in the
population.1 5 7 Furthermore, those with a current foot
ulcer typically require frequent wound dressing
changes4 32 within the average length of hospital admis-
sion.3 5 6 Overall, the primary and secondary reason for
admission ﬁndings indicate that 11.2% of all inpatients
need treatment for a foot-related condition during their
hospitalisation.
The type of hospital and ward also appeared to impact
on the prevalence of people admitted due to a
foot-related condition. Our ﬁndings indicate major
general hospitals have higher prevalences of people
admitted with a foot-related condition than other hos-
pital types. Those admitted with a foot-related condition
as the primary reason were also more likely to be in a
surgical ward, whereas those admitted as a secondary
reason were mostly found in a medical ward. These ﬁnd-
ings may be explained by major general hospitals
housing more of the necessary surgical disciplines
needed to effectively manage complex foot-related con-
ditions,9–12 32–34 and thus more of these patients being
transferred to these hospitals. Although this study has
focused on inpatient explanations, the impact of avail-
able outpatient services cannot be discounted.6 This is
especially the case considering recent signiﬁcant reduc-
tions in diabetes-related foot disease admissions in
Table 4 Independent associated factors for secondary admissions for foot-related conditions using multivariate logistical
regression (ORs (95% CI))
Risk factor Unadjusted p Value Adjusted p Value
Model 1
Diabetes 5.46 (2.33 to 12.78) <0.001* 4.89 (2.07 to 11.57) <0.001*
Current foot ulcer 9.84 (4.13 to 23.45) <0.001* 4.94 (2.12 to 16.67) 0.001*
Model 1 results: Pseudo R2: 0.233;
Omnibus: df=2, p=<0.001
Missing: 1 (0.1%);
H&L: p=0.755
Pseudo R2: 0.259;
Omnibus: df=4, p=<0.001
Missing: 5 (0.7%);
H&L: p=0.425
Model 2
Diabetes 5.27 (2.23 to 12.45) <0.001* No confounders identified
Foot risk status <0.001*
Low risk Referent
At risk 2.19 (0.56 to 8.55) 0.258
High risk 2.81 (0.78 to 10.18) 0.116
Acute 16.12 (5.40 to 48.11) <0.001*
Model 2 results: Pseudo R2: 0.261;
Omnibus: df=4, p=<0.001
Missing: 2 (0.3%);
H&L: p=0.680
*p<0.05.
df, degrees of freedom; H&L, Hosmer and Lemeshow test; missing, excluded missing cases; NA, not applicable; Omnibus, Omnibus tests of
model coefficients; Pseudo R2, Nagelkerke R2.
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Queensland were reportedly associated with improved
outpatient multidisciplinary foot services.6
Implications for policymakers, clinicians and researchers
Our ﬁndings have signiﬁcant potential implications for
policymakers. To contextualise these ﬁnding, an
‘average’ 600-bed hospital could expect to manage 44
inpatients each night for the primary reason of a
foot-related condition, including 29 for foot disease and
13 for foot trauma. This equates to an annual direct cost
of $A15.6 million for an average hospital if assuming
$A971 (2015) per Australian hospital bed day.56
Forecasting this across Australia’s 49 153 public hospital
beds57 suggests Australia would need 3637 hospital beds
each night, or 1.33 million beds each year, at an annual
cost of $A1.29 billion to primarily manage foot-related
conditions. Assuming a conservative 13-day average
length of stay for foot-related conditions2–6 indicates
Australia has over 102 000 annual primary admissions
for foot-related conditions, including 67 600 for foot
disease and 27 600 for foot trauma. With cellulitis
ranked as the 10th leading cause of Australian public hos-
pital admissions with 35 248 admissions,58 these ﬁgures
would place foot-related conditions in the top 10 causes
of hospital admission in Australia. Interestingly, two-thirds
of these reported cellulitis admissions were infections in
the lower leg and foot.58 These ﬁgures are likely to be
conservative as they do not account for private hospitals,
surgical procedures, secondary foot-related admissions
and any other foot-related inpatient management.
These ﬁndings also suggest clinicians should focus
their inpatient foot-related strategies on foot disease and
foot trauma, regardless of diabetes. First, we recommend
using a simple foot risk screening tool,19 32 or foot ulcer
visual inspection, as admission triage strategies to
improve identiﬁcation of inpatient foot-related condi-
tions. Like recent amputation prediction tools,10 these
tools could also be enhanced by including critical PAD
in the acute foot category to further improve identiﬁca-
tion. Second, our ﬁndings indicate those people hospita-
lised for a foot-related condition had not previously
attended the recommended outpatient multidisciplinary
foot team members.4 6 11 32 Thus, we recommended all
people with foot-related conditions have access to out-
patient multidisciplinary foot teams, regardless of dia-
betes status. Third, our ﬁndings support other authors
recommending episodes of foot-related hospitalisation
should be an opportunity to triage inpatients into multi-
disciplinary foot teams for best practice care.22 28 59 Last,
it is suggested strategies already demonstrated to reduce
the inpatient diabetic foot burden should be considered
for all inpatients admitted for foot-related conditions,
such as triaging foot-related admissions into specialist
multidisciplinary foot wards.4 11 28 59
Our ﬁndings also support further research. First, to
conﬁrm the ﬁndings of this study, we recommend imple-
menting methodologically similar research in other
regions.1 11 59 Second, our ﬁndings support
recommendations that hospital discharge data coders
are trained to more accurately identify and code
foot-related condition admissions to enable more effect-
ive monitoring of standard hospital discharge data
sets.1 12 Third, we recommend reporting the use of
occupied hospital bed days, rather than whole admis-
sions, to more speciﬁcally measure the burden of hospi-
talisation. Fourth, the foot disease and foot trauma
factors identiﬁed in this study should be investigated for
‘up stream’ factors that may predict these foot-related
hospitalisations. Last, it is recommended that clinical
trials implementing strategies demonstrated to reduce
the inpatient diabetic foot disease burden should be
evaluated on all inpatients admitted for foot-related
conditions.
Strengths and weaknesses
This study has several strengths. First, the study’s ﬁnd-
ings are generalisable as we purposively investigated rep-
resentative hospitals that reported very similar
demographic, social determinant and medical history
characteristics to those reported in other large inpatient
studies.17 58 Second, this study recruited total participant
numbers <3% of the original sample size calculated,
reported a robust consent rate >80%,18 and no differ-
ences in demographic characteristics between consent-
ing and non-consenting inpatients. Third, the study
used a data collection instrument modiﬁed from a very
similar valid and reliable data collection instrument that
captured a range of standard self-reported or clinically
diagnosed foot-related variables.19 Fourth, data collec-
tors had previous similar data collection experience,
further speciﬁc training and reported high accuracy and
validity when tested against simulated cases and medical
records. Last, the multivariate models used in this study
were recommended to identify independent associated
factors after adjusting for identiﬁed confounders and
the sample size was large enough to account for over 50
variables.42 43
This study also had a number of limitations. First, the
study was cross-sectional and can only report on asso-
ciated factors and not causal relationships.41 Second, as
a point-prevalence study, it relies on the day of data col-
lection being representative of standard inpatient activ-
ity.18 Third, while excluding cognitively impaired
patients is standard,15–18 this may have introduced a
selection bias towards under-reporting foot-related con-
ditions as excluded patients were mostly older cognitively
impaired patients that have higher foot disease rates
than cognitively intact patients.60 Fourth, although
standard self-reported medical history and clinically
diagnosed foot-related variables were used, these were
not gold standard biomedical criteria and may under-
report medical conditions.10 17 34 Fifth, while the study
used a data collection instrument modiﬁed from an
existing valid and reliable instrument, it was only
retested against simulated cases and medical records,
which limits our knowledge on its validity and reliability
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for capturing these data.41 Last, as this study used over
100 statistical tests, there is the likelihood of a type 1 stat-
istical error.41–43
CONCLUSIONS
This is the ﬁrst study to investigate the burden caused by
people admitted to hospital because of foot-related con-
ditions within a representative inpatient population.
Findings indicate the burden is signiﬁcantly higher than
previously reported with 1 in every 13 inpatients in hos-
pital for the primary reason of a foot-related condition.
These patients were mostly affected by foot disease or
foot trauma, in major general hospitals and most did
not have diabetes. It is recommended that serious con-
sideration be given to future strategies to investigate and
intervene in this considerable, yet historically underap-
preciated, inpatient burden.
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